Key result
Hypoalgesia precedes hypertension and may serve as an early marker of genetic risk.
Why the study?
Decreased pain perception is associated with hypertension and may precede its onset, suggesting a common physiological mechanism in individuals at risk.
Should not yet change hypertension risk assessment; leaves open whether hypoalgesia improves prediction in prospective cohorts.
For almost two decades, researchers have demonstrated that hypertension is reliably associated with decreased perception of pain. More recently, a growing body of evidence has begun to suggest that hypoalgesia is not a consequence of high blood pressure, as the phenomenon precedes the onset of hypertension in individuals at risk for the disorder. This article provides a review of empirical evidence of decreased pain perception in normotensive persons with a family history of hypertension, elevated resting blood pressure, or exaggerated cardiovascular reactivity to stress. Based on the existing evidence, hypoalgesia is argued to be a correlate of dysregulation of central nervous system structures involved in both pain control and cardiovascular regulation in individuals who are genetically predisposed to develop high blood pressure. As such, hypoalgesia may serve as a valuable method of identifying individuals at greatest risk for hypertension.
No takes yet. Share an insight, caveat, or question.
Christopher R. France (1999) conducted a review in Hypertension. Hypoalgesia (decreased pain perception) was evaluated. Hypoalgesia precedes the onset of hypertension in at-risk individuals and may serve as a valuable marker for identifying those genetically predisposed to developing high blood pressure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: